Figure 1. Effectiveness parameters. (A) Carotid intima-media thickness (mm) variation by visit, all patients (T0, n = 40; T4, n = 40). (B) HbA1c (%) variation by visit, all patients (T0, n = 40; T4, n = 40). cIMT: carotid intima-media thickness. Paired samples t-test; *** p < 0.001.
.
https://doi.org/10.3390/biomedicines11051362
.
Conclusions: Our findings suggest the effect of injectable semaglutide on atherosclerosis as a key CV protective mechanism.
.
| Glycemic parameters: | |||
| Glycemia (mg/dL) | 176 ± 75 | 122 ± 22 | <0.001 |
| HbA1c (%) | 9 ± 2 | 7 ± 1 | <0.001 |
| Carotid IMT | 1 ± 0.1 | 0.9 ± 0.1 | <0.001 |
IMT voltando como marcador de risco cardiovascular e marcador substituto.